Altimmune Announces Oral Presentation of Pemvidutide Clinical Data at Upcoming EASL International Liver Congress™ on June 25, 2022
GAITHERSBURG, Md., June 17, 2022 -- Altimmune, Inc. , a clinical-stage biopharmaceutical company, today announced that Dr. Stephen A. Harrison, Medical Director, Pinnacle Clinical Research, will... | June 17, 2022
Source: marketscreener.com